C Sabanayagam1, A Shankar, S C Lim, J Lee, E S Tai, T Y Wong. 1. Department of Community Medicine, West Virginia University School of Medicine, PO Box 9190, Morgantown, WV 26506-9190, USA. csabanayagam@hsc.wvu.edu
Abstract
AIMS/HYPOTHESIS: Prediabetes, an early stage in the hyperglycaemic continuum, increases the future risk of developing diabetes and cardiovascular disease (CVD). C-reactive protein (CRP), a marker of inflammation, is associated with diabetes and CVD. However, studies examining the association between CRP and prediabetes among participants without diabetes are limited. METHODS: We analysed data from two large population-based studies in Singapore: the Singapore Prospective Study Programme (SP2, n = 4,252 Chinese, Malay and Indians aged ≥ 24 years) and the Singapore Malay Eye Study (SiMES, n = 2,337 Malays aged 40-80 years), participants of which were free of diabetes mellitus. Prediabetes was defined as glycated haemoglobin of 5.7-6.4% in SiMES (n = 1,231); fasting plasma glucose of 5.6-6.9 mmol/l in SP2 (n = 386). RESULTS: Elevated high sensitivity CRP (hsCRP) levels were found to be associated with prediabetes after adjusting for age, sex, race-ethnicity, education, smoking, alcohol consumption, hypertension, BMI and total cholesterol. Comparing those with hsCRP <1 mg/l (referent), the OR (95% confidence interval) of prediabetes in persons with hsCRP 1-3 mg/l and >3 mg/l was 1.31 (0.99-1.74) and 2.17 (1.61-2.92), p (trend) < 0.0001 in SP2; 1.23 (1.00-1.52) and 1.31 (1.06-1.64), p (trend) = 0.02 in SiMES. In subgroup analysis, the association was stronger in women, Chinese and Malays, and participants with BMI < 25 kg/m(2). CONCLUSIONS: Data from two population-based Asian cohorts suggest that elevated serum hsCRP levels are associated with prediabetes.
AIMS/HYPOTHESIS: Prediabetes, an early stage in the hyperglycaemic continuum, increases the future risk of developing diabetes and cardiovascular disease (CVD). C-reactive protein (CRP), a marker of inflammation, is associated with diabetes and CVD. However, studies examining the association between CRP and prediabetes among participants without diabetes are limited. METHODS: We analysed data from two large population-based studies in Singapore: the Singapore Prospective Study Programme (SP2, n = 4,252 Chinese, Malay and Indians aged ≥ 24 years) and the Singapore Malay Eye Study (SiMES, n = 2,337 Malays aged 40-80 years), participants of which were free of diabetes mellitus. Prediabetes was defined as glycated haemoglobin of 5.7-6.4% in SiMES (n = 1,231); fasting plasma glucose of 5.6-6.9 mmol/l in SP2 (n = 386). RESULTS: Elevated high sensitivity CRP (hsCRP) levels were found to be associated with prediabetes after adjusting for age, sex, race-ethnicity, education, smoking, alcohol consumption, hypertension, BMI and total cholesterol. Comparing those with hsCRP <1 mg/l (referent), the OR (95% confidence interval) of prediabetes in persons with hsCRP 1-3 mg/l and >3 mg/l was 1.31 (0.99-1.74) and 2.17 (1.61-2.92), p (trend) < 0.0001 in SP2; 1.23 (1.00-1.52) and 1.31 (1.06-1.64), p (trend) = 0.02 in SiMES. In subgroup analysis, the association was stronger in women, Chinese and Malays, and participants with BMI < 25 kg/m(2). CONCLUSIONS: Data from two population-based Asian cohorts suggest that elevated serum hsCRP levels are associated with prediabetes.
Authors: Aruna D Pradhan; Nancy R Cook; Julie E Buring; JoAnn E Manson; Paul M Ridker Journal: Arterioscler Thromb Vasc Biol Date: 2003-03-06 Impact factor: 8.311
Authors: Athena W P Foong; Seang-Mei Saw; Jing-Liang Loo; Sunny Shen; Seng-Chee Loon; Mohamad Rosman; Tin Aung; Donald T H Tan; E Shyong Tai; Tien Y Wong Journal: Ophthalmic Epidemiol Date: 2007 Jan-Feb Impact factor: 1.648
Authors: Catherine C Cowie; Keith F Rust; Earl S Ford; Mark S Eberhardt; Danita D Byrd-Holt; Chaoyang Li; Desmond E Williams; Edward W Gregg; Kathleen E Bainbridge; Sharon H Saydah; Linda S Geiss Journal: Diabetes Care Date: 2008-11-18 Impact factor: 17.152
Authors: Dennis Ellenbroek; Jochen Kressler; Rachel E Cowan; Patricia A Burns; Armando J Mendez; Mark S Nash Journal: J Spinal Cord Med Date: 2014-03-12 Impact factor: 1.985
Authors: Zhen Wang; Hong Zhang; Xu-Hui Shen; Kui-Li Jin; Guo-Fen Ye; Wei Qiu; Li Qian; Bo Li; Yong-Hong Zhang; Guo-Ping Shi Journal: Ann Med Date: 2012-10-30 Impact factor: 4.709
Authors: K L Ong; A W K Tso; A Xu; L S C Law; M Li; N M S Wat; K A Rye; T H Lam; B M Y Cheung; K S L Lam Journal: Diabetologia Date: 2011-07-05 Impact factor: 10.122
Authors: Brunella Capaldo; Procolo Di Bonito; Michele Iaccarino; Mary J Roman; Elisa T Lee; Richard B Devereux; Gabriele Riccardi; Barbara V Howard; Giovanni de Simone Journal: Diabetes Care Date: 2012-12-05 Impact factor: 19.112